Breast Cancer

Bridging the Gap: Metastatic Breast Cancer

"Dr. Hahn's beside manner is what helps me stay as positive as I am."


Obesity Lowers Breast Cancer Risk in Young Women

Young women with high body fat levels are less likely to develop breast cancer before menopause, suggests a study conducted by an international team of researchers led by the National Institutes of Health (NIH).

By Diane Domina

10 Facts About BRCA Gene Mutations

Hereditary breast and ovarian cancer have been associated with mutations in two genes, BRCA1 and BRCA2. Here’s what you should know.

By Elizabeth Millard

All About BRCA1, BRCA2 Gene Mutation: Basic Explainer Story

Learn about a real-life experience with the gene mutation as well as your risk of cancer; cancer types if you have the mutation; and insurance coverage for any preventative treatment.

By Elizabeth Millard

How Do You Tell Your Family Members You Have the BRCA1, 2 Genetic Mutation?

You thought finding out you had the BRCA1 or 2 gene mutation was tough – but now you have to tell your family members they might be at risk for it, too. Experts give advice on what to tell them when.

By Bethany Kandel

Genetic Counselor Explains BRCA Genetic Mutations

Dana Clark, M.S., L.C.G.C., at the Basser Center for BRCA at Penn Medicine, discusses when you’re at a high risk for BRCA gene mutations, what testing involves, and what misconceptions she commonly encounters.

By Elizabeth Millard

Meet the Experts

PJ Hamel

Patient Expert

Bethany Kandel

Health Writer

Bethany Kandel is a New York-based journalist, health writer, and author. She is also a breast cancer survivor.

Phyllis Johnson

Patient Expert

PJ Hamel

Patient Expert

Health News

Higher Vitamin D Levels Linked to Lower Breast Cancer Risk

Results of a recent study suggest low blood levels of vitamin D are associated with an increased risk for breast cancer in women over the age of 55.

Potential New Treatment for Aggressive Breast Cancer Identified

Researchers from the Mayo Clinic in Rochester, Minnesota, discovered that an FDA-approved treatment for certain cancers of the blood may significantly reduce the growth of triple-negative breast cancers.

FDA Okays Genetic Home Test for Cancer

This week, the U.S. Food and Drug Administration (FDA) authorized 23andMe to market the first direct-to-consumer test for three specific genetic mutations known to increase the risk for breast, ovarian, and prostate cancer. Called the Personal Genome ...